The largest database of trusted experimental protocols

Anti cd105 antibody

Manufactured by R&D Systems
Sourced in United States

The Anti-CD105 antibody is a laboratory reagent used for the detection and analysis of CD105 (Endoglin), a transmembrane glycoprotein expressed on endothelial cells. This antibody can be used in various immunoassay techniques to identify and study CD105-positive cells.

Automatically generated - may contain errors

2 protocols using anti cd105 antibody

1

Directed Differentiation of Rat iPSCs into Adipocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
After expansion of each group of riPSCs, they were compacted to form EBs in hanging drops for 2 days. Over the following 3 days, they were exposed to 1×10-6 M RA in culture medium followed by washing for 1 day without RA. After 6 days, the EBs were plated onto gelatin-coated dishes and then incubated with 850 nM insulin (Sigma) and 20 nM 3,3,5-triiodo-l-thyronine (T3; Sigma) in basic-DMEM. MSCs expressing CD105 in developing EBs were sorted by MACS by using both an anti-CD105 antibody (R&D Systems) and an anti-rat IgG antibody conjugated with magnetic beads (Miltenyi Biotec). The sample preparation, magnetic labeling, and magnetic separation with mini-MS columns were conducted according to the manufacturer's instructions. After MACS separation, CD105+ MSCs were transferred to gelatin-coated dishes. For further induction to adipocytes, they were maintained in 850 nM insulin, 20 nM T3, and 1 µM dexamethasone (Dex; D8779, Sigma) in basic DMEM. In addition, 16 µM recombinant rat leptin (400-21; PeproTech, Rocky Hill, NJ) was supplemented for some MSCs from both groups of rat iPSCs, i.e., o-riPSCs and l-riPSCs. The culture medium was changed every day.
+ Open protocol
+ Expand
2

Rat Adipose-Derived Stem Cell Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
ADSCs of rats were digested by 0.25% trypsinase for 15 minutes at 37°C. After being washed twice with PBS, the cells were incubated with monoclonal antibodies, including anti-CD29 antibody (BioLegend, San Diego, CA, USA), anti-CD90 antibody (BioLegend), anti-CD105 antibody (R&D Systems, Inc., Minneapolis, MN, USA), anti-CD45 antibody (BioLegend), anti-CD106 antibody (BioLegend), or anti-CD34 antibody (BioLegend). The secondary antibodies, antirabbit or goat fluorescein isothiocyanate-conjugated antibodies (BD, Franklin Lakes, NJ, USA), were used according to the manufacturer’s instructions. Negative controls were conducted by omitting the primary antibodies. The scatter parameters of ADSCs were analyzed using FACScan flow cytometer (Beckman Coulter, Inc., Fullerton, CA, USA) and CellQuest analysis software (BD).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!